Perspectives
E-cigarette or vaping product use-associated lung injury (EVALI): a cautionary tale
Maitri Munsif, Mark Hew, Eli Dabscheck,
Corresponding Author
Eli Dabscheck
Alfred Health, Melbourne, VIC
Search for more papers by this authorMaitri Munsif, Mark Hew, Eli Dabscheck,
Corresponding Author
Eli Dabscheck
Alfred Health, Melbourne, VIC
Search for more papers by this authorPodcast with Eli Dabscheck available at mja.com.au/podcasts
No abstract is available for this article.
References
- 1 National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. Washington (DC): National Academies Press, 2018. https://www.nap.edu/read/24952 (viewed Feb 2020).
- 2 US Department of Health and Human Services. Smoking cessation: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020. https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf (viewed Feb 2020).
- 3Eissenberg T, Bhatnagar A, Chapman S, et al. Invalidity of an oft-cited estimate of the relative harms of electronic cigarettes. Am J Public Health 2020; 110: 161–162.
- 4Pearson JL, Villanti AC. It is past time to consider cannabis in vaping research. Nicotine Tob Res 2020; 22: 597–598.
- 5Hartnett KP, Kite-Powell A, Patel MT, et al. Syndromic surveillance for e-cigarette, or vaping, product use — associated lung injury. N Engl J Med 2019; 382: 766–772.
- 6Lozier M, Wallace B, Anderson K, et al. Update: demographic, product, and substance-use characteristics of hospitalized patients in a nationwide outbreak of e-cigarette, or vaping, product use — associated lung injuries — United States, December 2019. MMWR Morb Mortal Wkly Rep 2019; 68: 1142–1148.
- 7Cullen KA, Gentzke AS, Sawdey MD, et al. e-Cigarette use among youth in the United States, 2019. JAMA 2019; 322: 2095–2103.
- 8Miech RA, Patrick ME, O'Malley PM, Johnston LD, Bachman JG. Trends in reported marijuana vaping among US adolescents, 2017–2019. JAMA 2020; 323: 475–476.
- 9Gentzke AS, Creamer M, Cullen KA, et al. Vital signs: tobacco product use among middle and high school students — United States, 2011–2018. MMWR Morb Mortal Wkly Rep 2019; 68: 157–164.
- 10King BA, Jones CM, Baldwin GT, et al. The EVALI and youth vaping epidemics — implications for public health. N Engl J Med 2020; 382: 689–691.
- 11Morgan J, Breitbarth AK, Jones AL. Risk versus regulation: an update on the state of e-cigarette control in Australia. Intern Med J 2019; 49: 110–113.
- 12Wolfenden L, Stockings E, Yoong SL. Regulating e-cigarettes in Australia: implications for tobacco use by young people. Med J Aust 2018; 208: 89. https://www.mja.com.au/journal/2018/208/1/regulating-e-cigarettes-australia-implications-tobacco-use-young-people.
- 13Dunlop S, Dessaix A, Currow D. How are tobacco smokers using e-cigarettes? Patterns of use, reasons for use and places of purchase in New South Wales [letter]. Med J Aust 2016; 205: 336. https://www.mja.com.au/journal/2016/205/7/how-are-tobacco-smokers-using-e-cigarettes-patterns-use-reasons-use-and-places-0.
- 14Guerin N, White V. ASSAD 2017 Statistics and Trends: Australian secondary school students’ use of tobacco, alcohol, over-the-counter drugs, and illicit substances. Melbourne: Cancer Council Victoria, 2018. https://www.cancervic.org.au/downloads/cbrc/R18_NG_ASSAD_2017_National_Report.pdf (viewed Feb 2020).
- 15Layden JE, Ghinai I, Pray I, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin — final report. N Engl J Med 2020; 382: 903–916.
- 16 Centers for Disease Control and Prevention. Outbreak of lung injury associated with e-cigarette use, or vaping products [website]. Atlanta, GA: CDC, 2020. https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html (viewed June 2020).
- 17Siegel DA, Jatlaoui TC, Koumans EH, et al. Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury — United States. MMWR Morb Mortal Wkly Rep 2019; 68: 919–927.
- 18Schier JG, Meiman JG, Layden J, et al. Severe pulmonary disease associated with electronic-cigarette-product use — interim guidance. MMWR Morb Mortal Wkly Rep 2019; 68: 787–790.
- 19Blount BC, Karwowski MP, Shields PG, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med 2019; 382: 697–705.
- 20Kalininskiy A, Bach CT, Nacca NE, et al. E-cigarette, or vaping, product use associated lung injury (EVALI): case series and diagnostic approach. Lancet Respir Med 2019; 7: 1017–1026.
- 21Butt YM, Smith ML, Tazelaar HD, et al. Pathology of vaping-associated lung injury. N Engl J Med 2019; 381: 1780–1781.
- 22Chivers E, Janka M, Franklin P, et al. Nicotine and other potentially harmful compounds in “nicotine-free” e-cigarette liquids in Australia. Med J Aust 2019; 210: 127–128. https://www.mja.com.au/journal/2019/210/3/nicotine-and-other-potentially-harmful-compounds-nicotine-free-e-cigarette.
